Innovating Works

Oxford Endovascular Limited

Desconocido
OXIFLOW: Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patien... OXFORD ENDOVASCULAR LIMITED tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Each year ~51,000 EU citizens suffer a subarachnoid haemorrhage (SAH) resulting from the rupture of an intracranial aneurysm (IA), of whom 4...
2019-06-27 - 2024-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.